Vagus Nerve Stimulators Market to Witness Growth in the forecast period (2019-2026)

The market report titled ‘Global Vagus Nerve Stimulators Market – Size, Share and Forecast (2019-2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

Global Vagus Nerve Stimulators Market Drivers and Restraints
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years. Neurological disorders contribute to 92 million DALYs in 2005 projected to increase to 103 million in 2030 (approx. a 12% increase). While Alzheimer and other dementia are projected to show a 66% increase from 2005 to 2030, there is an estimated 57% decrease in DALYs associated with poliomyelitis, tetanus, meningitis and Japanese encephalitis combined.

Get a free sample of the report - https://www.datamintelligence.com/research-report/vagus-nerve-stimulators-market

Vagus Nerve Stimulators Market Segment Analysis
On the basis of type, the implantable VNS devices accounted for the largest market share in 2018 and is expected to remain dominant over the forecast period, 2019-2026. Implantable VNS devices are the highest revenue generating segment in vagus nerve stimulator market as the vagus nerve stimulator implanted devices are currently being approved for the treatment of refractory epilepsy and depression only. Additionally, results from many ongoing clinical studies are in pipeline. The use of implantable vagus nerve stimulators is associated with major complications such as cardiac dysrhythmias, both at the time of implantation and post-operative implantation. After examining the effects in 130 patients implanted with a vagus nerve stimulators between 2000 and 2013, it was observed that there is an increased response rate from 22.1 to 43.8% from the first to the fifth year of vagus nerve stimulators implantation.
By application, the Epilepsy held the largest market share in 2018. According to the WHO (World Health Organization), more than 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally, and nearly 80% of people with epilepsy live in low- and middle-income countries in 2019. For the treatment of epilepsy, the demand for VNS devices is increasing.

Global Vagus Nerve Stimulators Market Regional Analysis
The North America region occupied the largest market share of the global vagus nerve stimulators market in 2018 and is expected to remain dominant over the forecast period, due to increase in advanced healthcare system along with ease of availability of medical devices.
Europe and the Asia Pacific are also growing rapidly with a growing market value over the forecast period. Owing to increased government support and high awareness among consumers for advanced healthcare and research in medicine are driving the growth of the vagus nerve stimulators market in Europe. Asia Pacific market is growing at a high CAGR over the forecast period due to the rising incidence of neurological disorders of various types in this region. In addition, governments in emerging economies are increasingly extending support for advanced healthcare practices, hence fuelling the demand for vagus nerve stimulators in this region.

Global Vagus Nerve Stimulators Market Company Trends
Key players in the Vagus Nerve Stimulators market include Medtronic PLC, Electrocore LLC, Livanova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Biocontrol Medical, Bioness Inc., Enteromedics Inc., Nevro Corporation, and Neuropace Inc.
The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with an increased focus on R&D are other ways the leading players improve their market presence.

Read more information about the research report - https://www.datamintelligence.com/research-report/vagus-nerve-stimulators-market

This report contains the following table of contents-
1. Global Vagus Nerve Stimulators Market Methodology and Scope
1.1. Research methodology
1.2. Research Objective and Scope of the Report
2. Global Vagus Nerve Stimulators Market – Market Definition and Overview
3. Global Vagus Nerve Stimulators Market – Executive Summary
3.1. Market Snippet By Type
3.2. Market Snippet By Application
3.3. Market Snippet By End-User
3.4. Market Snippet by Region
3.5. DataM CLO Scenario
4. Global Vagus Nerve Stimulators Market – Market Dynamics
4.1.Market Impacting Factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Global Vagus Nerve Stimulators Market – Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
6. Global Vagus Nerve Stimulators Market – By Type
6.1. Introduction
6.1.1. Market Size Analysis, By Type Segment
6.1.2. Market Attractiveness Index, By Type Segment
6.2. Implantable VNS Devices
6.2.2.1. Bite-wing X-rays
6.2.2.2. Periapical X-rays
6.2.2.3. Occlusal X-rays
6.3. External VNS Devices
7. Global Vagus Nerve Stimulators Market – By Application
7.1. Introduction
7.1.1. Market Size Analysis, By Technology Segment
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Depression
7.3. Epilepsy
7.4. Migraine
7.5. Others
8. Global Vagus Nerve Stimulators Market – By End-User
8.1.Introduction
8.1.1. Market Size Analysis, By Application Segment
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals
8.3. Ambulatory Surgical Centers (ASCS)
8.4. Others
9. Global Vagus Nerve Stimulators Market – By Region
9.1. Introduction
9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.3. Market Attractiveness Index, By Region
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. South America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of South America
9.5. Asia Pacific
9.5.1. China
9.5.2. India
9.5.3. Japan
9.5.4. Australia
9.5.5. Rest of Asia Pacific
9.6. The Middle East and Africa
10.Global Vagus Nerve Stimulators Market – Competitive Landscape
10.1. Competitive Scenario
10.2. Competitor Strategy Analysis
10.3. Comparative Product Portfolio Analysis
10.4. Market Positioning/Share Analysis
10.5. Mergers and Acquisitions Analysis
11. Vagus Nerve Stimulators Market – Company Profiles
11.1. Electrocore LLC
11.1.1. Company overview
11.1.2. Product portfolio and description
11.1.3. Key highlights
11.1.4. Financial overview
11.2. Medtronic PLC
11.3. LivaNova PLC
11.4. Neuropace Inc
11.5. Enteromedics Inc.
11.6. Nevro Corporation
11.7. Boston Scientific Corporation
11.8. Aleva Neurotherapeutics SA
11.9. Bioness Inc.
11.10. Biocontrol Medical
12. Vagus Nerve Stimulators Market – Premium Insights
13. Vagus Nerve Stimulators Market – DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

This release was published on openPR.